(141 days)
For the quantitative determination of creatine kinase in serum. For IN VITRO diagnostic use.
Creatine Kinase-SL Assay, Catalogue Number 326-10, 326-30
The provided text is a 510(k) clearance letter from the FDA for the "Creatine Kinase-SL Assay" and does not contain the detailed information required to describe acceptance criteria and associated study results. The letter confirms substantial equivalence to a predicate device but does not specify performance metrics, study designs, sample sizes, or ground truth methodologies.
Therefore, I cannot provide the requested information based on the given input.
§ 862.1215 Creatine phosphokinase/creatine kinase or isoenzymes test system.
(a)
Identification. A creatine phosphokinase/creatine kinase or isoenzymes test system is a device intended to measure the activity of the enzyme creatine phosphokinase or its isoenzymes (a group of enzymes with similar biological activity) in plasma and serum. Measurements of creatine phosphokinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.(b)
Classification. Class II.